Next week our scientists are visiting San Antonio for the annual Society of Toxicology (SOT) conference.
Here is a list of our activities at this year’s SOT.
Monday 12th March
Absence of in vitro mutagenic and genotoxic properties of two superficial tobacco extracts
Scott, K. Le Godec, T. Crooks, C. Allbutt, B. Nightingale, J. McAdam, K. Meredith, C.
15:00* – CC Exhibit Hall | 1506/P724
Tuesday 13th March
A highlight of this year’s SOT conference, our Chief Scientific Officer, Dr Chris Proctor, will be taking part in a roundtable event on the evaluations of next-generation nicotine products. Be there at 11:00am, this is not to be missed!
Alternative Toxicology Approaches to Evaluate Next-Generation Nicotine Products
Chairperson: Jack Fowle
Speakers: Erin Hill, Warren Casey, Thomas Hartung, Christopher Proctor
The in vitro biological assessment of a tobacco heating product and comparison with a cigarette smoke.
Breheny, D. Adamson, J. Bozhilova, S. Jaunky, T. Taylor, M. Santopietro, S. Terry, A. Thorne, D. Gaҫa, M.
13:30 – CC Exhibit Hall | 2371/P725
In vitro RNA-seq-based toxicogenomics assessment shows reduced biological effect of tobacco heating products when compared to cigarette smoke
Haswell, L. Corke, S. Jaunky, T. Santopietro, S. Baxter, A. Thorne, D. Minet, E. Gaça, M.
15:00 – CC Exhibit Hall | 1936/P269
The characterisation of a human two Organ-on-a-Chip (lung-liver) system which has the potential to measure systemic responses in vitro
Collaboration with CN Bio
Dalrymple, A. Kostrzewski, T. Maraver, P. Corke, S. Hughes, D. Gaca, M.
15:00 – CC Exhibit Hall | 2137/P474
We will be tweeting throughout the conference. Visit @BAT_Sci for updates!
Wednesday 14th March
An Integrated Multi-Organ Culture System to Evaluate Tobacco Extract Systemic Responses
Collaboration with IONTOX
Hibbard, N. Dalrymple, A. Corpus, B. Baxter, A. Gaca, M. McKim, J.
09:15 – CC Exhibit Hall | 3132/P760
The assessment of native undiluted e-cigarette aerosol in vitro using 3D reconstituted human airway epithelium
Bishop E. Haswell L. Adamson J. Costigan. S. Thorne D. Gaca M.
10:45 – CC Exhibit Hall | 2799/P321
Reversibility of in vitro biological effects in cigarette smoke- exposed 3D lung tissues following switching to a tobacco heating product
Haswell, L. Corke, S. Jaunky, T. Santopietro, S. Baxter, A. Thorne, D. Minet, E. Dalrymple, A. Gaça, M.
10:45 – CC Exhibit Hall | 2798/P320
Comparative in vitro toxicological evaluation of novel tobacco heating product
Thorne, D. Breheny, D. Kendall, B. Proctor, C. Gaca, M.
10:45 – CC Exhibit Hall | 2807/P329
Nicotine characterization of an in vitro inhalation exposure system using conventional and next generation tobacco products: a US/UK interlaboratory comparison
Collaboration with IIVS
Aragon, M. Adamson, J. Behrsing, H. Sheehan, D. Gaca, M. Raabe, H.
13:00 – CC Exhibit Hall | 2371/P725
Thursday 15th March
Cytotoxicity Response of Combustible Cigarette and Electronic Nicotine Delivery System in a 3D Human Oral Tissue Model
Collaboration with Reynolds American International
Keyser, B. Dalrymple, A. Thorne, D. Hollings, M. Seymour, A. Gaca, M. Fields, W.
08:30 – CC Hall 1 | P190
A clinical study investigating changes in exposure to cigarette smoke chemicals in Japanese smokers who switch to using a tobacco heating product for a five-day period
Gale, N. Hardie, G. McEwan, M. Eldridge, A. Errington, G. McDermott, S. Glew, J. Hedge, A. Murphy, J. Proctor, C. Fearon, I.
08:30 – CC Hall 1 | 3513/P303
A clinical study investigating changes in exposure to cigarette smoke chemicals in UK smokers who switch to using a tobacco heating product over a five-day period
McEwan, M. Gale, N. Eldridge, A. Errington. G. Graff. D. Murphy. J. Proctor. C. Fearon, I.
08:30 – CC Hall 1 | 3517/P307
An interlaboratory in vitro toxicological assessment of next generation nicotine delivery products (NGPs)
Collaboration with Japan Tobacco International
Ito, S. Taylor, M. Mori, S. Thorne, D. Oke, O. Bozhilova, S. Terry, A. Pop, R. Breheny, D. Yoshino, K. Gaca, M. Nishino, T. Proctor, C.
08:30 – CC Hall 1 | 3561/P353
Human In-Vitro Models for Respiratory Toxicology: Evaluation of Goblet Cell Hyperplasia, Mucus Production, and Ciliary Beating Assays
Collaboration with IIVS TWS
Aragon, M. Frentzel, S. Hoeng, J. Ito, S. Ishikawa, S. Budde, J. Maione, A. Hayden, P. Haswell, L. Azzopardi, D. Keyser, B. Fields, W. Behrsing, H.
08:30 – CC Hall 1 | 3220/P101
All poster materials will be fully available online after the event, however, be sure to come by
and meet us if you’re at the conference!
If however, you cannot attend, then keep an eye on our Twtter (@BAT_Sci) feed throughout the week for updates on all our activities.
*Please note all times are local – CST.
NOTES TO EDITORS
BAT is a leading, multi-category consumer goods business, established in 1902. Our purpose is to build A Better Tomorrow by reducing the health impact of our business through offering a greater choice of enjoyable and less risky products for our consumers. The company has announced a target of increasing the number of its non-combustible product consumers from 11 million to 50 million by 2030; and to achieve at least £5 billion in New Categories revenues in by 2025.
+44 (0) 20 7845 2888 (24 hours)